Pharmacokinetics of Intraperitoneal and Intravenous Meropenem, Ampicillin, Aztreonam and Ciprofloxacin in Automated Peritoneal Dialysis Patients Without Peritonitis

Clinical trial NCT07113587 · COMPLETED

Trial details

NCT number: NCT07113587
Sponsor: Karl Landsteiner Insitute for Nephrology and Haemato-Oncology
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Peritoneal Dialysis-associated Peritonitis Peritoneal Dialysis (PD)Pharmacokinetics Intravenous Administration Intravenous Meropenem Intraperitoneal Ampicillin Aztreonam Ciprofloxacin Minimum Inhibitory Concentration (MIC)

Start date: 2014-04-08
Primary completion: 2017-07-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.